MMR and Autism: A Careful Reading
A retrospective study of MMR vaccination and autism examined records from more than 2.5 million US children. Its primary analysis found no increased rate of recorded childhood autism diagnoses after first vaccination before age 2. Unequal follow-up,…
THC Lowers Peak Eye Pressure, but Glaucoma Benefit Remains Unproven
medical cannabis research: A five-study meta-analysis found a measurable peak eye-pressure reduction after THC, but the control comparison was not statistically significant. These findings do not establish sustained pressure control, vision protection,…
High-Potency Education, Chronic Pain Care-Seeking, and the Federal Rescheduling Pause
CED Clinic physician review of 3 key developments: evaluating an art-based public health exhibit on high-potency cannabis, survey data on care engagement among 770 Canadian adults with chronic pain, and practical clinical implications of the federal…
Greensboro Police Raid Seizes 210 Pounds of Illicit Cannabis and 19 Firearms: Public Safety, Unregulated Supply Chains, and Clinical Harm Reduction
cannabis news digest: A structured CED Clinic overview of 3 key developments in cannabis regulation, market milestones, and scientific research. It keeps the evidence readable for patients and clinicians. The main study limits remain important for…
Endocannabinoid System and Opioids: What a New Review Says About Pain and OUD
A review in Expert Opinion on Therapeutic Targets examined therapeutic activation of the endocannabinoid system for opioid use disorder, chronic pain, and cancer-related pain. Dr. Caplan reviews this endocannabinoid system opioid use disorder research…
Patent Watch: Trait Targets Yeast Metabolism for C
The application’s title identifies a yeast-based system designed to increase production of UDP-glucose, a sugar donor used in glycosylation reactions. This suggests a manufacturing approach for sugar-linked cannabinoids rather than a finished…
Patent Watch: Defloria Targets Autism With CW1AS1
The application identifies a cannabinoid extract designated CW1AS1 for treating autism and associated symptoms. The available disclosure does not specify active pharmaceutical ingredients, cannabinoid ratios, excipients, dosing, or delivery mechanisms,…
Cannabinoids in Psychiatric Care: What New Clinical Trials Reveal About CBD & Psychosis
cannabis news digest: A structured CED Clinic overview of 3 key developments in cannabis regulation, market milestones, and scientific research. It keeps the evidence readable for patients and clinicians. The main study limits remain important for…
Autism Animal Studies Suggest New Treatment Targets, Not Proven Patient Therapies
medical cannabis research: A systematic review of 52 animal studies reports behavioral changes after diverse drug and microbiota interventions. The findings identify research directions, but do not establish effective autism treatments, cannabis dosing,…
Prenatal THC Vapor Models, Medication Dosing, and Dispensary Neighborhood Safety
cannabis news digest: A structured CED Clinic overview of 3 key developments in cannabis regulation, market milestones, and scientific research. It keeps the evidence readable for patients and clinicians. The main study limits remain important for…
